Annual Drug Patent Expirations for BIDIL
Bidil is a drug marketed by Arbor Pharms Llc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has four patent family members in four countries.
The generic ingredient in BIDIL is hydralazine hydrochloride; isosorbide dinitrate. One supplier is listed for this compound. Additional details are available on the hydralazine hydrochloride; isosorbide dinitrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
